• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

非小细胞肺癌完全切除术后复发的预测。

Prediction of recurrence after complete resection in patients with NSCLC.

机构信息

Second Department of Surgery, University of Occupational and Environmental Health, Kitakyushu, Japan.

出版信息

Anticancer Res. 2012 Sep;32(9):3953-60.

PMID:22993343
Abstract

A proportion of lung cancer patients develop recurrence, even after curative resection. This study reviewed the literature, focusing on the key words: recurrence, relapse, relapse-free survival, disease-free survival (DFS), surgery, and non-small cell lung cancer (NSCLC), not overall survival (OS) to evaluate the post-operative risk factors for tumor recurrence after surgery. This article reviews the current status and progress on this subject.

摘要

一部分肺癌患者即使经过根治性切除后仍会出现复发。本研究对文献进行了回顾，重点关注关键词：复发、复发、无复发生存期、无病生存期（DFS）、手术和非小细胞肺癌（NSCLC），而不是总生存期（OS），以评估手术后肿瘤复发的术后危险因素。本文综述了这一主题的现状和进展。

相似文献

1
Prediction of recurrence after complete resection in patients with NSCLC.非小细胞肺癌完全切除术后复发的预测。
Anticancer Res. 2012 Sep;32(9):3953-60.
2
Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.完全切除的Ⅰ期非小细胞肺癌局部复发后的复发后生存情况。
Thorax. 2009 Mar;64(3):192-6. doi: 10.1136/thx.2007.094912.
3
Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.在接受根治性切除的I期非小细胞肺癌患者的非肿瘤性肺组织中，基质金属蛋白酶-2（MMP-2）活性升高与肿瘤复发及不良生存相关。
J Surg Oncol. 2007 Mar 15;95(4):337-46. doi: 10.1002/jso.20643.
4
Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.癌胚抗原（CEA）和糖类抗原125（CA125）在可切除非小细胞肺癌复发和转移方面的临床价值
Anticancer Res. 2003 Jul-Aug;23(4):3427-32.
5
Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.与根治性切除 I-II 期肺癌患者复发相关的因素。
Lung Cancer. 2011 Aug;73(2):222-9. doi: 10.1016/j.lungcan.2010.11.013. Epub 2010 Dec 18.
6
Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.Ⅰ期非小细胞肺癌复发的临床和分子预测因素。
Ann Thorac Surg. 2012 May;93(5):1606-12. doi: 10.1016/j.athoracsur.2012.01.048. Epub 2012 Mar 20.
7
Bronchial resection margin length and clinical outcome in non-small cell lung cancer.支气管切除边缘长度与非小细胞肺癌的临床结局。
Eur J Cardiothorac Surg. 2011 Nov;40(5):1151-6. doi: 10.1016/j.ejcts.2011.02.042. Epub 2011 Mar 30.
8
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.基于现行分期系统，肿瘤大小对 1A 期非小细胞肺癌解剖性肺切除术后结局的影响。
J Thorac Cardiovasc Surg. 2012 Feb;143(2):390-7. doi: 10.1016/j.jtcvs.2011.10.023. Epub 2011 Dec 9.
9
Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.单中心25年间T4期非小细胞肺癌的初次手术结果：获益值得冒险。
Ann Thorac Surg. 2008 Oct;86(4):1065-75; discussion 1074-5. doi: 10.1016/j.athoracsur.2008.07.004.
10
Density of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumors.肿瘤浸润淋巴细胞密度与大非小细胞肺癌患者疾病复发和生存相关。
J Surg Res. 2011 May 15;167(2):207-10. doi: 10.1016/j.jss.2009.08.029. Epub 2009 Sep 23.

引用本文的文献

1
Non-small cell lung cancer (NSCLC): characteristics, risk factors, molecular profile patterns, and treatment - a retrospective cohort study from Palestine.非小细胞肺癌（NSCLC）：特征、危险因素、分子图谱模式及治疗——来自巴勒斯坦的一项回顾性队列研究
J Egypt Natl Canc Inst. 2025 Jul 14;37(1):40. doi: 10.1186/s43046-025-00298-8.
2
Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT.PET-CT在肺癌诊断与预后中的机器学习应用
Cancer Manag Res. 2024 Apr 24;16:361-375. doi: 10.2147/CMAR.S451871. eCollection 2024.
3
Human NTHL1 expression and subcellular distribution determines cisplatin sensitivity in human lung epithelial and non-small cell lung cancer cells.
人类NTHL1的表达及亚细胞分布决定了人肺上皮细胞和非小细胞肺癌细胞对顺铂的敏感性。
NAR Cancer. 2024 Feb 21;6(1):zcae006. doi: 10.1093/narcan/zcae006. eCollection 2024 Mar.
4
Conditional survival analysis of patients with resected non-small cell lung cancer.接受手术切除的非小细胞肺癌患者的条件生存分析
JTCVS Open. 2023 Sep 18;16:948-959. doi: 10.1016/j.xjon.2023.09.010. eCollection 2023 Dec.
5
Prognosis of recurrence after complete resection in early-stage lung adenocarcinoma based on molecular alterations: a systematic review and meta-analysis.基于分子改变的早期肺腺癌完全切除术后复发的预后：系统评价和荟萃分析。
Sci Rep. 2023 Oct 31;13(1):18710. doi: 10.1038/s41598-023-42851-2.
6
Estimation of an Image Biomarker for Distant Recurrence Prediction in NSCLC Using Proliferation-Related Genes.基于增殖相关基因的 NSCLC 远处复发预测的影像生物标志物的评估。
Int J Mol Sci. 2023 Feb 1;24(3):2794. doi: 10.3390/ijms24032794.
7
Identification of metabolic genes for the prediction of prognosis and tumor microenvironment infiltration in early-stage non-small cell lung cancer.用于预测早期非小细胞肺癌预后和肿瘤微环境浸润的代谢基因鉴定
Open Life Sci. 2022 Aug 11;17(1):881-892. doi: 10.1515/biol-2022-0091. eCollection 2022.
8
Prediction of Two-Year Recurrence-Free Survival in Operable NSCLC Patients Using Radiomic Features from Intra- and Size-Variant Peri-Tumoral Regions on Chest CT Images.利用胸部CT图像上肿瘤内及大小变异的瘤周区域的放射组学特征预测可手术切除的非小细胞肺癌患者的两年无复发生存率
Diagnostics (Basel). 2022 May 25;12(6):1313. doi: 10.3390/diagnostics12061313.
9
Machine learning application in personalised lung cancer recurrence and survivability prediction.机器学习在个性化肺癌复发和生存预测中的应用。
Comput Struct Biotechnol J. 2022 Apr 4;20:1811-1820. doi: 10.1016/j.csbj.2022.03.035. eCollection 2022.
10
The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study.癌症干细胞对肺腺癌和鳞状细胞癌复发风险的影响：一项前瞻性队列研究。
Stem Cells Transl Med. 2022 Mar 31;11(3):239-247. doi: 10.1093/stcltm/szab029.